Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Procter & Gamble | 2.86% | $1.08M | $337.63B | -15.08% | 69 Neutral | |
| Goldman Sachs Group | 2.69% | $1.01M | $273.17B | 55.14% | 73 Outperform | |
| International Business Machines | 2.58% | $970.63K | $284.68B | 35.08% | 79 Outperform | |
| Citigroup | 2.56% | $961.17K | $217.50B | 70.37% | 68 Neutral | |
| Morgan Stanley | 2.39% | $897.17K | $288.70B | 41.88% | 76 Outperform | |
| AbbVie | 2.18% | $820.71K | $406.30B | 27.10% | 66 Neutral | |
| Merck & Company | 2.15% | $808.70K | $264.21B | 6.59% | 80 Outperform | |
| Analog Devices | 2.09% | $786.33K | $135.91B | 27.29% | 78 Outperform | |
| Verizon | 2.05% | $772.57K | $170.01B | -0.10% | 81 Outperform | |
| Union Pacific | 1.98% | $745.81K | $139.42B | 1.70% | 72 Outperform |